Elevance Health (ELV) Stock Forecast — 2-Week Outlook

StockMap's current 2-week read on Elevance Health (ELV) is Neutral.

The composite score behind that read is -0.01, weighing +0.27 of bullish evidence against -0.22 bearish.

Elevance Health last closed at $394.51, +2.09% on the session.

Against the IVW growth benchmark the position is +1.17% over the forecast window.

The read is built from 13 underlying insights — 5 bullish and 8 bearish.

Agreement across those insights is 62%.

Elevance Health has no graded predictions yet. We publish our accuracy across thousands of stocks in the open, misses included.

On the fundamentals StockMap ranks Elevance Health in the 55th percentile on valuation and the 63rd percentile on return on equity, where 100 is best.

Elevance Health is classified under Health Care / Health Care Providers & Services, with a market capitalisation of $83.80B.

StockMap tracks Elevance Health as the 5th largest of the 72 companies it covers in the Health Care Providers & Services industry, part of the Health Care sector.

Across that group the current two-week reads are 48 Neutral, 23 Moderate Underperform and 1 Moderate Outperform.

On that composite Elevance Health ranks 6th of 72 in the group, against a group median of -0.13.